Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Bad News for Blood Thinners?

Earlier this week, Motley Fool health-care bureau chief Brenton Flynn discussed Johnson & Johnson's (NYSE: JNJ  ) failed attempt to get its blood thinner Xarelto approved by the FDA for a lucrative new treatment area. In this video, Brenton tells us about one headwind that could potentially impact sales of blood thinners across the board. If a device coming out from Boston Scientific (NYSE: BSX  ) to prevent blood clots due to atrial fibrillation receives approval in the U.S., it could be worth half a billion dollars for the company, and could slightly weigh on blood thinner sales, if successful. Brenton tells us which companies could be affected by this under-the-radar trend.

Is bigger really better?
Involved in everything from baby powder to biotech, Johnson & Johnson's critics are convinced that the company is spread way too thin. If you want to know if J&J is nothing but a bloated corporate whale -- or a well-diversified giant that's perfect for your portfolio -- check out The Fool's new premium report outlining the Johnson & Johnson story in terms that any investor can understand. Claim your copy by clicking here now.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2300376, ~/Articles/ArticleHandler.aspx, 9/28/2016 2:51:30 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,318.05 89.75 0.49%
S&P 500 2,168.11 8.18 0.38%
NASD 5,310.24 4.53 0.09%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 2:35 PM
BSX $23.70 Down -0.03 -0.11%
Boston Scientific CAPS Rating: ***
JNJ $119.42 Up +0.20 +0.17%
Johnson and Johnso… CAPS Rating: *****
BMY $55.30 Down -0.44 -0.79%
Bristol-Myers Squi… CAPS Rating: ****
PFE $33.99 Up +0.16 +0.46%
Pfizer CAPS Rating: ****